2022
DOI: 10.1016/j.healun.2022.01.636
|View full text |Cite
|
Sign up to set email alerts
|

Thromboembolism After Lung Transplantation - Prolonged Anticoagulation Prophylaxis Depending on Age and Body Weight?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…22 Since there is a known increased risk of VTE with lung transplantation and associated increased morbidity/mortality, some institutions have proposed long-term prophylaxis in higher-risk patients with Lovenox or novel oral anticoagulations such as apixaban. 23 24…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…22 Since there is a known increased risk of VTE with lung transplantation and associated increased morbidity/mortality, some institutions have proposed long-term prophylaxis in higher-risk patients with Lovenox or novel oral anticoagulations such as apixaban. 23 24…”
Section: Discussionmentioning
confidence: 99%
“…22 Since there is a known increased risk of VTE with lung transplantation and associated increased morbidity/mortality, some institutions have proposed long-term prophylaxis in higher-risk patients with Lovenox or novel oral anticoagulations such as apixaban. 23,24 Despite the significant benefit from pharmacologic VTE prophylaxis in patients following lung transplantation, there are a few instances that complicate its utilization. First, renal impairment and acute kidney injury are not uncommon in the postoperative transplant patients and some of the anticoagulant medications, like Lovenox, are renally cleared.…”
Section: Prevention Of Pulmonary Embolismmentioning
confidence: 99%